tiprankstipranks
Advertisement
Advertisement
MediWound Q2 2026 Results Highlight EscharEx Trial Progress and New NexoBrid BARDA Agreement
PremiumCompany AnnouncementsMediWound Q2 2026 Results Highlight EscharEx Trial Progress and New NexoBrid BARDA Agreement
9d ago
MDWD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MDWD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
11d ago
Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)
Premium
TipRanks Newswire
Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)
1M ago
MediWound Earnings Call: Promise Amid Near-Term Strain
PremiumCompany AnnouncementsMediWound Earnings Call: Promise Amid Near-Term Strain
3M ago
MediWound Q1 2026 Results Highlight EscharEx Trial Progress and BARDA Boost for NexoBrid
Premium
Company Announcements
MediWound Q1 2026 Results Highlight EscharEx Trial Progress and BARDA Boost for NexoBrid
3M ago
MediWound reports Q1 EPS (23c), consensus (66c)
Premium
The Fly
MediWound reports Q1 EPS (23c), consensus (66c)
3M ago
MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid
PremiumCompany AnnouncementsMediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid
5M ago
MediWound says Vericel awarded ten-year contract valued at up to $197M
Premium
The Fly
MediWound says Vericel awarded ten-year contract valued at up to $197M
5M ago
MediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus
Premium
Company Announcements
MediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100